Blood test guides safer radiation for throat cancer

NCT ID NCT05962242

Recruiting now Disease control Sponsor: University of Virginia Source: ClinicalTrials.gov ↗

First seen Feb 05, 2026 · Last updated May 22, 2026 · Updated 21 times

Summary

This study is for people with HPV-related throat cancer who need radiation therapy. Researchers are using a blood test that tracks tumor DNA to decide if a lower dose of radiation can be safely given to the neck. The goal is to keep the cancer under control while reducing side effects. About 90 adults will take part in this phase 2 trial.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SQUAMOUS CELL CARCINOMA OF THE OROPHARYNX are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Bon Secours
NOT_YET_RECRUITING

Richmond, Virginia, 23114, United States

Contact
Eastern Virginia Medical School
NOT_YET_RECRUITING

Norfolk, Virginia, 23507, United States

Contact
Miami Cancer Institute
RECRUITING

Miami, Florida, 33176, United States

Contact Phone: •••-•••-•••• Email: •••••@•••••

Contact
University of Virginia
RECRUITING

Charlottesville, Virginia, 22908, United States

Contact

Contact Phone: •••-•••-•••• Email: •••••@•••••
Virginia Commonwealth University
RECRUITING

Richmond, Virginia, 23284, United States

Contact Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

SQUAMOUS CELL CARCINOMA OF THE OROPHARYNX